ENDOCYTE INC's ticker is ECYT and the CUSIP is 29269A102. A total of 65 filers reported holding ENDOCYTE INC in Q3 2017. The put-call ratio across all filers is 2.37 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2018 | $145,000 | +866.7% | 15,972 | +53.1% | 0.00% | – |
| Q3 2017 | $15,000 | -6.2% | 10,433 | -0.3% | 0.00% | – |
| Q2 2017 | $16,000 | -46.7% | 10,462 | -10.8% | 0.00% | – |
| Q1 2017 | $30,000 | -97.7% | 11,728 | -94.6% | 0.00% | -100.0% |
| Q3 2014 | $1,318,000 | -5.0% | 216,734 | +2.9% | 0.00% | -25.0% |
| Q2 2014 | $1,388,000 | – | 210,605 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 4,211,302 | $74,793,000 | 19.97% |
| VHCP Management III, LLC | 600,000 | $10,656,000 | 8.05% |
| RA Capital Management | 6,196,143 | $110,043,000 | 5.88% |
| GREAT POINT PARTNERS LLC | 1,606,100 | $28,524,000 | 4.44% |
| Avoro Capital Advisors LLC | 5,301,718 | $94,159,000 | 4.32% |
| Ghost Tree Capital, LLC | 1,100,000 | $19,536,000 | 4.15% |
| Crosspoint Capital Strategies, LLC | 104,573 | $1,857,000 | 3.04% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,514,084 | $62,410,000 | 2.24% |
| NEXTHERA CAPITAL LP | 654,532 | $11,624,000 | 2.23% |
| EMORY UNIVERSITY | 148,628 | $2,640,000 | 1.73% |